800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
SponsoredMethadone Clinics in cities of Arizona
Medication treatment for opioid use disorder in Arizona
Arizona’s treatment landscape for opioid use disorder (OUD) is shaped by a single statewide Medicaid agency, a network of opioid treatment programs concentrated in Maricopa and Pima counties, and a growing role for telehealth in counties where the nearest clinic is hours away. All three FDA-approved medications for opioid use disorder, methadone, buprenorphine (including Suboxone), and naltrexone (including the Vivitrol injection), are available in the state through both clinic-based and office-based care. The listings on this page connect you to programs across Arizona; what follows is the context to help you choose where to start.
Your medication and setting options
There are three FDA-approved medications for opioid use disorder, and they are not interchangeable. Methadone is a long-acting opioid agonist that reduces withdrawal and cravings. Under federal law, methadone for OUD is dispensed only through a federally certified opioid treatment program (OTP), not a regular pharmacy. Buprenorphine, including Suboxone and other buprenorphine-naloxone products and the extended-release injection Sublocade, is a partial agonist with a ceiling effect that lowers overdose risk. Any clinician with a standard DEA registration that includes Schedule III authority can prescribe it from an office and have it filled at a pharmacy, or you can receive it through a clinic. Naltrexone, including the monthly Vivitrol injection, is not an opioid and blocks the effects of opioids; any licensed prescriber can prescribe it, but treatment can only begin after you have been off opioids long enough to avoid precipitated withdrawal (often seven to ten days, your clinician decides).
The two settings are an OTP (sometimes called a methadone clinic, though many OTPs also offer buprenorphine and naltrexone) and office-based opioid treatment with a prescriber who writes the prescription and a pharmacy that fills it. An OTP tends to mean more structure and on-site dosing early in treatment; an office-based provider tends to mean fewer visits once you are stable. Neither is better in the abstract; what fits depends on the medication you want, your work and family schedule, and what is reachable from where you live. The comparison between methadone and Suboxone goes deeper on the trade-offs.
How Arizona pays for treatment and the rules that shape access
The Arizona Health Care Cost Containment System (AHCCCS, pronounced “access”) is the state’s single Medicaid agency and the largest payer for substance use treatment in Arizona, covering roughly 2 million members as of late 2025. AHCCCS covers all three medications for OUD under both fee-for-service and managed care plans, with no copay for naloxone at AHCCCS-contracted pharmacies. Behavioral health is delivered through AHCCCS Complete Care plans, AHCCCS Complete Care plans with a Regional Behavioral Health Agreement (ACC-RBHAs), and Tribal Regional Behavioral Health Authorities (TRBHAs) for members of federally recognized tribes who choose tribal care. The agency reported approximately 37,685 members using medication treatment for OUD in State Fiscal Year 2025 and approximately $582 million spent on substance use treatment that year (AHCCCS, 2026).
Federal rules updated in 2024 (42 CFR Part 8) expanded take-home methadone doses, up to a 28-day supply for patients who are stable in treatment, allowed treatment to start by telehealth, authorized mobile medication units, and removed the older requirement that a person have a one-year history of addiction to enter an OTP. Eligibility for take-homes is decided by the program, on a schedule that adds days as you stabilize. Staying consistent with your dose is one of the strongest predictors of those take-home tiers.
For buprenorphine telehealth, federal flexibilities allow treatment to be started by audio-video and, in many cases, audio-only telehealth without a prior in-person visit; the current temporary extension runs through December 31, 2026, alongside a separate buprenorphine telemedicine final rule that took effect December 31, 2025 (DEA and HHS, 2026). AHCCCS covers telehealth, which matters in counties where the closest OTP is in another part of the state.
Naloxone, the medication that reverses an opioid overdose, is available at every Arizona-licensed pharmacy under a standing order from the Arizona Department of Health Services (ADHS) and as an over-the-counter Narcan product. Arizona’s Good Samaritan law (A.R.S. 13-3423), part of the 2018 Arizona Opioid Epidemic Act, protects a person who calls for help during an overdose from prosecution for possession of a controlled substance or paraphernalia tied to that call. Privacy and employment protections are a separate question many people ask about; the short answer is that treatment records are protected by federal 42 CFR Part 2 and HIPAA.
Where Arizona stands on overdose deaths
Arizona recorded 1,651 opioid overdose deaths in 2024, with 97.9% involving prescription or synthetic opioids, primarily illicit fentanyl, according to the Arizona Department of Health Services (ADHS, 2025). The 2024 figure was a roughly 9.5% decline from 2023 across reporting county medical examiners. The counties with the highest rates of opioid overdose deaths per 100,000 residents in 2024 were Mohave, Pima, Maricopa, Graham, and Coconino. In Maricopa County, fentanyl was involved in 59% of fatal overdoses that year and methamphetamines in 67%, reflecting the fentanyl-with-stimulants pattern now common across the state (Maricopa County Department of Public Health, 2025).
Provisional 2025 data point to a rebound that runs against the national trend. A peer-reviewed analysis of CDC data published in 2026 found that Arizona overdose deaths from January through August 2025 were roughly 20% higher than the same period in 2024, with deaths involving synthetic opioids up about 40%, increases that were most pronounced among Hispanic and Non-Hispanic Black residents (opioid use disorder is treatable, and starting medication is the single most effective response). Numbers like these describe real loss; treatment exists in every county the figures cover.
Starting MOUD treatment in Arizona
Most paths into treatment begin with an assessment, either at an OTP, an office-based provider, an emergency department, or by telehealth. AHCCCS members and uninsured Arizonans can call the state’s Opioid Assistance and Referral (OAR) Line, run by ADHS, for help finding a provider. Same-day or fast-start access is realistic for buprenorphine in many parts of the state because a prescription can be filled at a pharmacy that day; methadone induction happens at the OTP and may take a day or two to schedule. If you are starting buprenorphine after using illicit fentanyl, the timing of the first dose matters: starting too soon can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician will time it carefully. The listings on this page show outpatient programs across Arizona; inpatient or residential care is a separate pathway and is typically used when withdrawal management or stabilization needs to happen before outpatient medication treatment continues.
Treatment for specific Arizona communities and situations
Federally recognized tribes in Arizona, including the Navajo Nation, the Tohono O’odham Nation, the White Mountain Apache, and others, can receive behavioral health services through the American Indian Health Program or through a TRBHA. The Indian Health Service and tribally operated clinics in Arizona offer MOUD, and AHCCCS coordinates with tribal authorities on coverage. The recent enforcement action against fraudulent sober-living homes that targeted Indigenous people, addressed by Arizona legislation in 2025 expanding ADHS oversight and licensing of sober-living facilities, is part of why verifying that a program is AHCCCS-credentialed matters before you commit to it.
For people leaving jails and prisons, Maricopa County is using its share of opioid settlement funds to start MOUD during incarceration and connect people to community providers at release; Arizona’s share of the One Arizona Agreement settlement is up to $1.215 billion over 18 years. For pregnant patients, methadone and buprenorphine during pregnancy are the recommended standard of care; Plan of Safe Care reporting in Arizona is a health-and-safety planning process, and seeking treatment is what the guidance asks of you. Family members helping someone start treatment often find it useful to know that MOUD is medical treatment, not a substitute drug.
Frequently asked questions
Does AHCCCS cover methadone and Suboxone?
Yes. AHCCCS covers methadone, buprenorphine (including Suboxone and Subutex), and naltrexone (including Vivitrol) for opioid use disorder under both fee-for-service and managed care plans, along with the counseling and behavioral health services that go with them (AHCCCS, 2026). Coverage details and any prior authorization requirements depend on your specific AHCCCS plan.
Can I start buprenorphine by telehealth in Arizona?
Often, yes. Current federal rules allow buprenorphine to be started by audio-video and, in many cases, audio-only telehealth without a prior in-person visit. The current temporary extension runs through December 31, 2026, alongside a separate permanent buprenorphine telemedicine rule that took effect December 31, 2025 (DEA and HHS). Confirm what is current with the specific provider you contact.
Do I have to go to a clinic every day for methadone?
Early in treatment, yes, most days, because the program is establishing a stable dose. As you stabilize, federal rules updated in 2024 allow take-home doses up to a 28-day supply, on a graduated schedule the program manages based on how you are doing in treatment. How long methadone treatment lasts is decided with your clinician; some people stay on it for years, and that is appropriate care for a chronic condition.
Is buprenorphine just substituting one drug for another?
No. Buprenorphine and methadone are medications that, taken as prescribed, stabilize the brain systems opioid use disorder has dysregulated; they reduce cravings and overdose risk and let people work, parent, and live ordinary lives. National clinical guidance from SAMHSA and NIDA treats them as first-line care. The question of dependence versus addiction is a fair one to raise with your clinician.
Where can I get naloxone in Arizona?
At any Arizona-licensed pharmacy, under a standing order from ADHS that lets the pharmacist dispense it without a prescription, and as an over-the-counter Narcan product. AHCCCS covers naloxone with no copay for members. Community distribution sites and county health departments also hand it out. Arizona’s Good Samaritan law protects a person who calls for help during an overdose.
About this page
Last reviewed June 2026. Sources: Arizona Department of Health Services (Opioid Overdoses Surveillance Report, 2023; Opioid Update, May 2025); AHCCCS Annual Substance Use Treatment Report, SFY 2025 (April 2026); Maricopa County Department of Public Health Overdose Data Dashboard (2025); Arizona Attorney General’s Office, One Arizona Agreement; A.R.S. 13-3423 and SB1211 (2024); SAMHSA, 42 CFR Part 8 Final Rule (2024); DEA and HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities (effective January 1, 2026); DEA and HHS, Expansion of Buprenorphine Treatment via Telemedicine Encounter (effective December 31, 2025); FDA approval information for methadone, buprenorphine products, and naltrexone; Lippold et al., peer-reviewed analysis of Arizona overdose deaths January-August 2025 (2026).
Methadone Centers is not a medical provider and does not provide treatment, diagnoses, or clinical advice. Information on this page is for general education and does not substitute for care from a licensed clinician. Decisions about medication and setting should be made with a qualified provider who knows your medical history.
The helpline featured on this site is answered by a paid sponsor and is not affiliated with every program listed in our directory. Calls are confidential. Listings on this page are independent of any sponsorship and reflect provider information from public sources; verify hours and availability with the program directly.